FDA regulation

Marks

Pharma

FDA turmoil compounds challenges for cell and gene therapy field

To innovators in the cell and gene therapy field, Peter Marks’ exit from the FDA means losing a seasoned regulator and key ally.

Angus Liu Apr 2, 2025 3:16pm

children on phones

Senators urge FDA to fix gaping holes in oversight of DTC ads

Feb 20, 2024 6:22am

Congress building

Congress weighs new FDA powers in accelerated approvals: WSJ

Jun 10, 2022 10:14am